Mouse models show that respiratory infections from viruses such as influenza and SARS-CoV-2 can trigger metastasis of dormant breast cancer cells in the lungs, a finding supported by epidemiological d...

Wafik El-Deiry: 'Tremendous Uncertainty' For Cancer Research in US / cancer, Cancer research, Jay Bhattacharya, OncoDaily, Oncology, Wafik El-Deiry

Cardiac Biomarkers Linked to Future Cancer Risk, Even in People without Heart Disease, UCLA Health Study Suggests / cancer, Cancer and heart disease, cancer

Background Breast cancer survivors treated with radiotherapy (RT) face elevated long-term risk of cardiovascular complications. Double product (DP), the product of systolic blood pressure and heart ra...

Assessing the association between baseline levels of cardiac biomarkers and future cancer risk is critical to understand the cross talk between cardio…

In this Review, Fabiani and colleagues summarize the management of anthracycline cardiotoxicity, including mechanisms, classification, risk stratification, prevention, diagnosis and treatment. The aut...

Chemotherapy with anthracyclines has revolutionized the management and outcomes of both solid tumours and haematologic malignancies.1 Notwithstanding, the

Data on left ventricular ejection fraction (LVEF) recovery in patients with anthracycline-induced cardiomyopathy (AIC) are limited.To evaluate LVEF re…

Background The optimal strategy for modern chemotherapy should be based on a comprehensive approach for cancer patients with cardiovascular diseases. Therefore, cardio-oncology has received increasi...

Sivatharshini Ramalingam, MD, and Charlotte Manisty, MBBS, PhD, discuss JACC: CardioOncology Expert Panel Recommendations for cardiovascular risk evaluation prior to cancer treatment, cardiac nuances ...

The field of cardio-oncology has traditionally focused on the impact of cancer and its therapies on cardiovascular health. Mounting clinical and preclinical evidence, however, indicates that the rever...

Patient recruitment is challenging for clinical trials. Here, the authors introduce TrialGPT, an end-to-end framework for zero-shot patient-to-trial matching with large language models.

ates have improved over the last two decades, the risk of CVD has risen over time in patients with cancer. CVD and cancer share similar risk factors and a common pathophysiology involving inflammation...

Background Breast cancer survivors face a higher risk of cardiovascular disease (CVD) compared to non-breast cancer patients, yet contemporary data on CVD-related mortality within this group remains s...

Despite advanced in targeted cancer therapies, anthracyclines remain essential in treating various malignancies, albeit with risks of cancer therapy-related cardiac dysfunction (CTRCD). Out of the myr...

Discover why JACC is the ultimate publishing partner for your cardiovascular research.

This editorial refers to ‘Anthracycline-induced cardiovascular toxicity: validation of the Heart Failure Association and International Cardio-Oncology Soci

A total of 973 patients with isolated tricuspid regurgitation. Severe tricuspid regurgitation (TR) is linked to high morbidity and mortality. Isolated TR offers limited treatment options beyond inter...

Purpose To evaluate right ventricular (RV) uptake measured by quantitative [99mTc]Tc-DPD SPECT/CT to investigate its role in predicting and evaluating prognosis and therapeutic outcomes in patients wi...

Background Clonal hematopoiesis of indeterminate potential (CHIP) has been shown to increase all-cause mortality and risk of cardiomyopathy in patients with solid malignancies. CHIP has also been show...

Key Points. Coronary calcium score calculated on pre-treatment PET/CT identifies lymphoma patients at risk of cardiac events after anthracycline therapyCor

PURPOSEGuidelines recommend cardiovascular (CV) risk assessment and counseling for cancer survivors. This study evaluated the automated heart-health assessment (AH-HA) clinical decision support tool t...